Skip to main content
Fig. 1 | BMC Cardiovascular Disorders

Fig. 1

From: Development of anthracycline-induced dilated cardiomyopathy due to mutation on LMNA gene in a breast cancer patient: a case report

Fig. 1

Progressive changes observed on electrocardiograms obtained from the proband. The first electrocardiogram (ECG) obtained 6 months after the beginning of the chemotherapy reported inactivable electrical zones at V1 and V3 leads with a cardiac axis of − 17°(a). The proband presented clinical signs of heart failure 48 months after treatment, an ECG at the time reported left anterior hemiblock and signs compatible with left cavities enlargement, cardiac axis − 46°(b

Back to article page
\